What does Dianthus Therapeutics, Inc. /DE/ (DNTH) do?

Dianthus Therapeutics, Inc. /DE/ (DNTH) is a publicly traded company in the Healthcare sector.

What sector does DNTH operate in?

Dianthus Therapeutics, Inc. /DE/ operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find DNTH earnings analysis?

AlphaOS publishes an earnings intelligence page for Dianthus Therapeutics, Inc. /DE/ (DNTH) covering results, guidance context, and AI-assisted analysis. See /stocks/DNTH/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

DNTH

Dianthus Therapeutics, Inc. /DE/

Healthcare · Pharmaceutical Preparations

$98.35Sep 22, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Dianthus Therapeutics, Inc. /DE/ shows decelerating business momentum based on AlphaOS pipeline evidence.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

DNTH's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on DNTH.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q4 2025

Full DNTH earnings analysis

Reported figures for Dianthus Therapeutics, Inc. /DE/ — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 30, 2026

What happened recently for Dianthus Therapeutics, Inc. /DE/ (DNTH) — events, not interpretation.

Event: Reported Q4 2025 revenue -100% YoY.
Also: Last session September 22, 2026 at $98.35.
Source: Q4 2025 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Dianthus Therapeutics, Inc. /DE/ — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Market cap:: $5.50B
Revenue:: $2.04M

DNTH earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Dianthus Therapeutics, Inc. /DE/ through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.